Abstract
Hyperglycemia is a common complication of extremely low birth weight infants (ELBW) which may have an impact upon their morbidity and mortality. Hyperglycemia in ELBW can occurred as result of many factors. We report a rare case of hyperglycemia in an ELBW infant after administration of a carbonic anhydrase inhibitor (acetazolamide), used for temporary management of posthemorrhagic hydrocephalus, our case was seen in one of the private hospital at Dammam city, Saudi Arabia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
